| Insurance Industry | Financials Sector | Mr. Itay Gal-Or CEO | TASE Exchange | IL0011712309 ISIN |
| Israel Country | 55 Employees | - Last Dividend | - Last Split | - IPO Date |
Imed Infinity Medical-Limited Partnership, established in 2020, stands as a beacon of innovation in the medical field, particularly emphasizing the burgeoning sector of digital health. Based in the vibrant technology hub of Tel Aviv, Israel, this partnership dedicates itself to the funding and support of cutting-edge research and development projects. By focusing on investments in the medical domain, Imed Infinity positions itself at the forefront of advancements that promise to redefine healthcare practices through digital means. The company's strategic location in Tel Aviv, a city known for its dynamic tech scene, further strengthens its ability to foster breakthroughs in digital health solutions.
Imed Infinity Medical-Limited Partnership specializes in a broad spectrum of investments within the medical field, with a keen focus on the digital health sector. Their portfolio encompasses a diverse range of projects, each poised to make significant contributions to the field of medicine through technological innovation. Below are the core areas of their investment:
At its core, Imed Infinity invests in groundbreaking research and development initiatives. These projects aim to innovate and improve existing medical technologies or develop new ones, with a strong emphasis on digital health solutions. This includes software for patient management, telehealth services, and wearable health technology, addressing current challenges in healthcare access and quality.
Focusing on the digital transformation of healthcare, Imed Infinity backs the development of digital health platforms that facilitate better patient care through advanced data analytics, AI-driven diagnostics, and digital therapy applications. These solutions aim to improve patient outcomes, reduce healthcare costs, and increase the efficiency of healthcare delivery.